Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis, and chronic cough... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RGSCX | 24.12 | 0.13 | +0.54% |
| Virtus KAR Global Small-Cap C | |||
| VKSIX | 20.27 | 0.07 | +0.35% |
| Virtus KAR Small-Mid Cap Core I | |||
| SUVZX | 12.88 | 0.03 | +0.23% |
| PGIM Quant Solutions Large-Cap Val Z | |||
| VLEOX | 59.52 | 0.06 | +0.10% |
| Value Line Small Cap Opportunities Inv | |||
| HBLTX | 14.73 | N/A | N/A |
| Hartford Balanced Income R5 | |||
A.I.dvisor tells us that AGNPF and CYDY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGNPF and CYDY's prices will move in lockstep.
| Ticker / NAME | Correlation To AGNPF | 1D Price Change % | ||
|---|---|---|---|---|
| AGNPF | 100% | N/A | ||
| CYDY - AGNPF | 24% Poorly correlated | -14.17% | ||
| WVE - AGNPF | 23% Poorly correlated | -5.12% | ||
| PHIO - AGNPF | 21% Poorly correlated | N/A | ||
| IBIO - AGNPF | 20% Poorly correlated | +6.34% | ||
| ABCZF - AGNPF | 12% Poorly correlated | N/A | ||
More | ||||